Product Program year 2020 Source: CMS Open Payments

WavelinQ

Device BD Interventional - Peripheral Intervention

Open in the dashboard

General payments

$148,344

266 payments

Research payments

$0

0 payments

Through program year 2020, $148,344 in general payments and $0 in research payments were reported against WavelinQ (BD Interventional - Peripheral Intervention).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $148,344 266

Breakdown

Who paid General payments · program year 2020
  1. Bard Peripheral Vascular, Inc. $138,032 257 payments
  2. Becton, Dickinson and Company $10,312 9 payments
Top recipients General payments · program year 2020
  1. Stephen Hohmann Vascular Surgery · Dallas, TX $35,264 24% · 11 payments
  2. Todd Berland Vascular Surgery · New York, NY $25,831 17% · 7 payments
  3. Alejandro Alvarez Nephrology · Florissant, MO $22,236 15% · 10 payments
  4. Neghae Mawla Nephrology · Plano, TX $18,293 12% · 9 payments
  5. Conrad Pun Vascular & Interventional Radiology · Madison, WI $7,436 5% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Vascular Surgery Surgery $72,802 49% · 46 practitioners
  2. Nephrology Internal Medicine $46,807 32% · 34 practitioners
  3. Vascular & Interventional Radiology Radiology $11,440 8% · 26 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $6,023 4% · 3 practitioners
  5. Neurological Surgery $4,375 3% · 1 practitioner

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Texas $59,508 40% · 6 recipients
  2. New York $28,951 20% · 3 recipients
  3. Missouri $22,236 15% · 1 recipient
  4. Wisconsin $10,782 7% · 6 recipients
  5. Illinois $6,334 4% · 6 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

266 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record